Genome Editing/Genome Engineering Market
Genome Editing/Genome Engineering Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
Genome Editing/Genome Engineering Market Size and Growth
The Genome Editing/Engineering market is rapidly growing, driven by advancements in CRISPR technology and rising demand for precision medicine. The market size was valued at approximately $5 billion in 2022 and is projected to reach around $20 billion by 2030, reflecting a significant CAGR fueled by innovation and increased applications.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Thermo Fisher Scientific
◍ Merck
◍ Horizon Discovery
◍ Genscript
◍ Sangamo Biosciences
◍ Integrated Dna Technologies
◍ Lonza
◍ New England Biolabs
◍ Origene Technologies
◍ Transposagen Biopharmaceuticals
◍ Editas Medicine
◍ Crispr Therapeutics
The genome editing market features key players like Thermo Fisher Scientific, Merck, and Editas Medicine. These companies offer innovative tools and technologies, driving advancements in CRISPR, gene therapy, and research applications, thereby broadening market scope. In 2022, Thermo Fisher reported approximately $40 billion in revenue, while Merck generated around $59 billion.
Request Sample Report
Market Segmentation
By Application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Request Sample Report
By Product
Market Growth
Request Sample Report
$ X Billion USD
